中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 37 Issue 7
Jul.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2021  >  37(7): 1553-1557

Interpretation of European Society for Clinical Nutrition and Metabolism practical guideline : Clinical nutrition in liver disease (2020)

DOI: 10.3969/j.issn.1001-5256.2021.07.015

  • Department of General Surgery of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China

Research funding:

National Natural Science Foundation of China (81774082)

  • Received Date: 2021-01-22
  • Accepted Date: 2021-02-20
  • Published Date: 2021-07-20
    Abstract
  • In December 2020, European Society for Clinical Nutrition and Metabolism (ESPEN) issued the latest practical guidelines for clinical nutrition in liver disease on the basis of the published ESPEN guidelines for clinical nutrition in liver disease and the latest clinical evidence. The guideline proposes 103 statements and recommendations for the nutritional and metabolic management of patients with acute liver failure, alcohol and nonalcoholic steatohepatitis, liver cirrhosis, and liver transplantation, which summarizes the principles and measures for clinical nutrition in diagnosis and treatment and provides more comprehensive guidance for nutrition program.

     

    • FullText(HTML)
  • loading
    • References(44)
  • [1]
    FISCHER JE, BOWER RH. Nutritional support in liver disease[J]. Surg Clin North Am, 1981, 61(3): 653-660. DOI: 10.1016/s0039-6109(16)42443-6.
    [2]
    PLAUTH M, MERLI M, KONDRUP J, et al. ESPEN guidelines for nutrition in liver disease and transplantation[J]. Clin Nutr, 1997, 16(2): 43-55. DOI: 10.1016/s0261-5614(97)80022-2.
    [3]
    PLAUTH M, CABRÉ E, RIGGIO O, et al. ESPEN guidelines on enteral nutrition: Liver disease[J]. Clin Nutr, 2006, 25(2): 285-294. DOI: 10.1016/j.clnu.2006.01.018.
    [4]
    PLAUTH M, CABRÉ E, CAMPILLO B, et al. ESPEN guidelines on parenteral nutrition: Hepatology[J]. Clin Nutr, 2009, 28(4): 436-444. DOI: 10.1016/j.clnu.2009.04.019.
    [5]
    PLAUTH M, BERNAL W, DASARATHY S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521. DOI: 10.1016/j.clnu.2018.12.022.
    [6]
    BISCHOFF SC, BERNAL W, DASARATHY S, et al. ESPEN practical guideline: Clinical nutrition in liver disease[J]. Clin Nutr, 2020, 39(12): 3533-3562. DOI: 10.1016/j.clnu.2020.09.001.
    [7]
    Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline developers' handbook[M]. Edinburgh: SIGN, 2001.
    [8]
    BISCHOFF SC, SINGER P, KOLLER M, et al. Standard operating procedures for ESPEN guidelines and consensus papers[J]. Clin Nutr, 2015, 34(6): 1043-1051. DOI: 10.1016/j.clnu.2015.07.008.
    [9]
    MCLEAN AE. Hepatic failure in malnutrition[J]. Lancet, 1962, 2(7269): 1292-1294. DOI: 10.1016/s0140-6736(62)90847-4.
    [10]
    WATERLOW JC. Amount and rate of disappearance of liver fat in malnourished infants in Jamaica[J]. Am J Clin Nutr, 1975, 28(11): 1330-1336. DOI: 10.1093/ajcn/28.11.1330.
    [11]
    TANDON P, RAMAN M, MOURTZAKIS M, et al. A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology, 2017, 65(3): 1044-1057. DOI: 10.1002/hep.29003.
    [12]
    BUNCHORNTAVAKUL C, REDDY KR. Review article: Malnutrition/sarcopenia and frailty in patients with cirrhosis[J]. Aliment Pharmacol Ther, 2020, 51(1): 64-77. DOI: 10.1111/apt.15571.
    [13]
    Nutritional status in cirrhosis. Italian multicentre cooperative project on nutrition in liver cirrhosis[J]. J Hepatol, 1994, 21(3): 317-325.
    [14]
    CEDERHOLM T, BOSAEUS I, BARAZZONI R, et al. Diagnostic criteria for malnutrition - An ESPEN Consensus Statement[J]. Clin Nutr, 2015, 34(3): 335-340. DOI: 10.1016/j.clnu.2015.03.001.
    [15]
    KONDRUP J, RASMUSSEN HH, HAMBERG O, et al. Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22(3): 321-336. DOI: 10.1016/s0261-5614(02)00214-5.
    [16]
    BORHOFEN SM, GERNER C, LEHMANN J, et al. The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis[J]. Dig Dis Sci, 2016, 61(6): 1735-1743. DOI: 10.1007/s10620-015-4015-z.
    [17]
    BARBOSA-SILVA MC, BARROS AJ. Bioelectrical impedance analysis in clinical practice: A new perspective on its use beyond body composition equations[J]. Curr Opin Clin Nutr Metab Care, 2005, 8(3): 311-317. DOI: 10.1097/01.mco.0000165011.69943.39.
    [18]
    KYLE UG, GENTON L, PICHARD C. Low phase angle determined by bioelectrical impedance analysis is associated with malnutrition and nutritional risk at hospital admission[J]. Clin Nutr, 2013, 32(2): 294-299. DOI: 10.1016/j.clnu.2012.08.001.
    [19]
    BELARMINO G, GONZALEZ MC, TORRINHAS RS, et al. Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis[J]. World J Hepatol, 2017, 9(7): 401-408. DOI: 10.4254/wjh.v9.i7.401.
    [20]
    ALVARES-DA-SILVA MR, REVERBEL DA SILVEIRA T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients[J]. Nutrition, 2005, 21(2): 113-117. DOI: 10.1016/j.nut.2004.02.002.
    [21]
    HANAI T, SHIRAKI M, NISHIMURA K, et al. Sarcopenia impairs prognosis of patients with liver cirrhosis[J]. Nutrition, 2015, 31(1): 193-199. DOI: 10.1016/j.nut.2014.07.005.
    [22]
    CRUZ-JENTOFT AJ, SAYER AA. Sarcopenia[J]. Lancet, 2019, 393(10191): 2636-2646. DOI: 10.1016/S0140-6736(19)31138-9.
    [23]
    MADDEN AM, MORGAN MY. Resting energy expenditure should be measured in patients with cirrhosis, not predicted[J]. Hepatology, 1999, 30(3): 655-664. DOI: 10.1002/hep.510300326.
    [24]
    NIELSEN K, KONDRUP J, MARTINSEN L, et al. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis[J]. Br J Nutr, 1993, 69(3): 665-679. DOI: 10.1079/bjn19930068.
    [25]
    NIELSEN K, KONDRUP J, MARTINSEN L, et al. Long-term oral refeeding of patients with cirrhosis of the liver[J]. Br J Nutr, 1995, 74(4): 557-567. DOI: 10.1079/bjn19950158.
    [26]
    NANDIVADA P, COWAN E, CARLSON SJ, et al. Mechanisms for the effects of fish oil lipid emulsions in the management of parenteral nutrition-associated liver disease[J]. Prostaglandins Leukot Essent Fatty Acids, 2013, 89(4): 153-158. DOI: 10.1016/j.plefa.2013.02.008.
    [27]
    JUREWITSCH B, GARDINER G, NACCARATO M, et al. Omega-3-enriched lipid emulsion for liver salvage in parenteral nutrition-induced cholestasis in the adult patient[J]. JPEN J Parenter Enteral Nutr, 2011, 35(3): 386-390. DOI: 10.1177/0148607110382023.
    [28]
    XU Z, LI Y, WANG J, et al. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults[J]. Clin Nutr, 2012, 31(2): 217-223. DOI: 10.1016/j.clnu.2011.10.001.
    [29]
    BERNAL W, AUZINGER G, DHAWAN A, et al. Acute liver failure[J]. Lancet, 2010, 376(9736): 190-201. DOI: 10.1016/S0140-6736(10)60274-7.
    [30]
    RUTHERFORD A, DAVERN T, HAY JE, et al. Influence of high body mass index on outcome in acute liver failure[J]. Clin Gastroenterol Hepatol, 2006, 4(12): 1544-1549. DOI: 10.1016/j.cgh.2006.07.014.
    [31]
    REINTAM BLASER A, STARKOPF J, ALHAZZANI W, et al. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines[J]. Intensive Care Med, 2017, 43(3): 380-398. DOI: 10.1007/s00134-016-4665-0.
    [32]
    MENDENHALL CL, MORITZ TE, ROSELLE GA, et al. Protein energy malnutrition in severe alcoholic hepatitis: Diagnosis and response to treatment. The VA Cooperative Study Group #275[J]. JPEN J Parenter Enteral Nutr, 1995, 19(4): 258-265. DOI: 10.1177/0148607195019004258.
    [33]
    Obesity: Preventing and managing the global epidemic. Report of a WHO consultation[J]. World Health Organ Tech Rep Ser, 2000, 894: i-xii, 1-253. DOI: 10.1017/s0021932003245508.
    [34]
    MORENO C, DELTENRE P, SENTERRE C, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids[J]. Gastroenterology, 2016, 150(4): 903-910. e8. DOI: 10.1053/j.gastro.2015.12.038.
    [35]
    FLANNERY AH, ADKINS DA, COOK AM. Unpeeling the evidence for the banana bag: Evidence-based recommendations for the management of alcohol-associated vitamin and electrolyte deficiencies in the ICU[J]. Crit Care Med, 2016, 44(8): 1545-1552. DOI: 10.1097/CCM.0000000000001659.
    [36]
    YUMUK V, TSIGOS C, FRIED M, et al. European guidelines for obesity management in adults[J]. Obes Facts, 2015, 8(6): 402-424. DOI: 10.1159/000442721.
    [37]
    CAMPOS-MURGUÍA A, RUIZ-MARGÁIN A, GONZÁLEZ-REGUEIRO JA, et al. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease[J]. World J Gastroenterol, 2020, 26(39): 5919-5943. DOI: 10.3748/wjg.v26.i39.5919.
    [38]
    PENG S, PLANK LD, MCCALL JL, et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: A comprehensive study[J]. Am J Clin Nutr, 2007, 85(5): 1257-1266. DOI: 10.1093/ajcn/85.5.1257.
    [39]
    SAM J, NGUYEN GC. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension[J]. Liver Int, 2009, 29(9): 1396-1402. DOI: 10.1111/j.1478-3231.2009.02077.x.
    [40]
    GLUUD LL, DAM G, LES I, et al. Branched-chain amino acids for people with hepatic encephalopathy[J]. Cochrane Database Syst Rev, 2015, (2): CD001939. DOI: 10.1002/14651858.CD001939.pub2.
    [41]
    AMODIO P, CANESSO F, MONTAGNESE S. Dietary management of hepatic encephalopathy revisited[J]. Curr Opin Clin Nutr Metab Care, 2014, 17(5): 448-452. DOI: 10.1097/MCO.0000000000000084.
    [42]
    LÖSER C, ASCHL G, HÉBUTERNE X, et al. ESPEN guidelines on artificial enteral nutrition—percutaneous endoscopic gastrostomy (PEG)[J]. Clin Nutr, 2005, 24(5): 848-861. DOI: 10.1016/j.clnu.2005.06.013.
    [43]
    SCHVTZ T, HUDJETZ H, ROSKE AE, et al. Weight gain in long-term survivors of kidney or liver transplantation—another paradigm of sarcopenic obesity?[J]. Nutrition, 2012, 28(4): 378-383. DOI: 10.1016/j.nut.2011.07.019.
    [44]
    ZHANG Y, CHEN J, WU J, et al. Probiotic use in preventing postoperative infection in liver transplant patients[J]. Hepatobiliary Surg Nutr, 2013, 2(3): 142-147. DOI: 10.3978/j.issn.2304-3881.2013.06.05.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1191) PDF downloads(356) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return